Pharmaceutical Manufacturer in Sarigam, GIDC, Vapi, Gujarat
Taj Pharma India Limited, headquartered in Sarigam, GIDC, Vapi, Gujarat, is one of India’s most trusted and EU-GMP, WHO-GMP, and ISO 9001:2018 certified pharmaceutical companies. With over a decade of excellence in manufacturing, Taj Pharma has become synonymous with innovation, integrity, and quality healthcare solutions.
A Legacy of Excellence: The Foundation of Taj Pharma India Limited
Established on June 28, 2011, Taj Pharma India Limited has continuously evolved to become a global pharmaceutical powerhouse. Registered under Registrar of Companies, Mumbai, with a Corporate Identification Number (CIN) U33111MH2011PLC219226, the company boasts a paid-up capital of ₹50 Crore and operates as a Public Limited Company.
Driven by a vision to enhance global healthcare accessibility, Taj Pharma focuses on manufacturing finished dosage forms—including tablets, capsules, oral jellies, creams, ointments, and other pharmaceutical products that meet international regulatory standards.
Leadership that Defines Taj Pharma’s Vision
At the heart of Taj Pharma’s success is its visionary leadership. Guided by distinguished directors—Dr. Ranvir Kumar Singh, Abhishek Singh, Shantanu Kumar Singh, and Priyanka Singh—the company operates with a mission to deliver world-class healthcare solutions. Their collective expertise has led Taj Pharma to achieve a sustainable growth trajectory in both domestic and international markets.
The leadership’s focus on ethical business practices, innovation, and transparency ensures that Taj Pharma remains a trusted name in the pharmaceutical and healthcare industry.
State-of-the-Art Manufacturing Infrastructure at Sarigam GIDC
Taj Pharma’s manufacturing facility at Sarigam GIDC, Gujarat, exemplifies advanced technology, efficiency, and regulatory compliance. The site is strategically located in the industrial hub of Vapi, providing superior connectivity for export operations.
Production Capacities:
- Tablets: 120 million per month
- Capsules: 40 million per month
- Oral Jellies: 60 million per month
The facility operates under strict adherence to cGMP (current Good Manufacturing Practices), ensuring that every product meets international safety, purity, and efficacy standards.
Certifications that Reinforce Quality and Trust
Taj Pharma’s dedication to quality is validated by globally recognized certifications:
- EU-GMP (European Union Good Manufacturing Practice) – Demonstrating adherence to European regulatory standards.
- WHO-GMP (World Health Organization – Good Manufacturing Practice) – Ensuring globally accepted quality benchmarks.
- ISO 9001:2018 – Reflecting commitment to continuous quality improvement.
- GLP and PIC/S Compliance – Ensuring laboratory practices align with global regulatory expectations.
These certifications reinforce Taj Pharma India Limited’s position as a trusted pharmaceutical manufacturer for regulated and semi-regulated markets worldwide.
Expertise Across Diverse Therapeutic Segments
Taj Pharma has built a diverse portfolio covering major therapeutic areas, ensuring access to affordable and high-quality medicines.
Key Focus Areas Include:
- Antiviral Formulations: Developing solutions for HIV, Hepatitis, and emerging viral diseases.
- Antidiabetic Medications: Innovating advanced formulations for Type 2 diabetes management.
- Cardiovascular Drugs: Addressing global cardiac healthcare needs.
- CNS (Central Nervous System) Treatments: Offering reliable solutions for neurological conditions.
- Oncology and Specialty Medicines: Manufacturing niche products for cancer care and rare diseases.
This comprehensive product portfolio enables Taj Pharma to cater to the evolving needs of healthcare systems across the globe.
Research, Innovation, and Quality Control
At Taj Pharma, innovation and quality are at the forefront of every initiative. The company’s in-house Research & Development (R&D) center works on formulation development, stability studies, and regulatory documentation, ensuring continuous improvement in process and product excellence.
The Quality Assurance (QA) and Quality Control (QC) teams at Taj Pharma play a pivotal role in guaranteeing that all products undergo rigorous testing at every stage of production—from raw material inspection to finished product release.
Each batch is evaluated under international pharmacopoeial standards (IP, BP, USP, EP), ensuring that products maintain consistency, stability, and therapeutic efficacy.
Global Footprint and Export Excellence
Taj Pharma has successfully expanded its footprint across Asia, Africa, the Middle East, CIS countries, and Latin America. Through strategic alliances and regulatory approvals in multiple international markets, Taj Pharma has emerged as a reliable global supplier of generic and branded formulations.
The company’s exports include a wide range of products—oral solids, liquids, injectables, and topical formulations—delivering quality medicines to millions worldwide. Taj Pharma’s reputation as a dependable contract manufacturer and exporter continues to strengthen its international partnerships.
Commitment to Sustainability and Ethical Practices
Beyond manufacturing excellence, Taj Pharma India Limited is dedicated to environmental sustainability and corporate social responsibility. The company follows eco-friendly manufacturing protocols, effective waste management systems, and energy-efficient operations to minimize environmental impact.
Taj Pharma’s ethical business model emphasizes transparency, fair trade, and community development, aligning with its mission of creating a healthier world.
Why Choose Taj Pharma India Limited?
Choosing Taj Pharma means partnering with a pharmaceutical manufacturer that values trust, quality, and compliance. Here’s why global clients prefer Taj Pharma:
- EU-GMP, WHO-GMP, and ISO 9001:2018 certified infrastructure
- Dedicated R&D and regulatory affairs team
- Wide therapeutic range with market-ready formulations
- Flexible contract manufacturing and private labeling services
- Consistent supply chain and global logistics support
- Commitment to affordability without compromising quality
Taj Nutra UK and the Purobein Advantage
Expanding its global reach, Taj Pharma Group also operates through its UK-based subsidiary Taj Nutra UK, specializing in nutraceuticals and sports nutrition under the premium brand Purobein.
These high-quality supplements reflect the group’s commitment to holistic wellness, catering to the growing demand for natural and preventive healthcare products.
The Future of Taj Pharma: Innovating for Tomorrow
Taj Pharma’s vision is to remain at the forefront of pharmaceutical innovation, continuously introducing new formulations that address unmet medical needs. With AI-assisted research, advanced manufacturing automation, and next-generation formulation technologies, the company is prepared to meet global healthcare challenges head-on.
By upholding its core values of quality, integrity, and innovation, Taj Pharma India Limited continues to shape a healthier, more sustainable future for patients worldwide.
Taj Pharma India Limited, based in Sarigam, GIDC, Vapi, Gujarat, stands as a beacon of trust, quality, and innovation in the global pharmaceutical landscape. With a robust regulatory foundation, world-class facilities, visionary leadership, and a strong ethical framework, Taj Pharma continues to redefine pharmaceutical excellence—one formulation at a time.
As the company expands its horizons through EU-GMP-certified manufacturing and global partnerships, it remains steadfast in its mission—to deliver affordable, high-quality healthcare solutions that improve lives worldwide.
Taj Pharma India Limited, based in Sarigam, GIDC, Vapi, Gujarat, is a leading EU-GMP, WHO-GMP, and ISO 9001:2018 certified pharmaceutical manufacturer known for its excellence in producing high-quality tablets, capsules, oral jellies, creams, and ointments. Established in 2011, the company operates with an authorized and paid-up capital of ₹50 Crore and is registered under the Registrar of Companies, Mumbai (CIN: U33111MH2011PLC219226).
Under the visionary leadership of Dr. Ranvir Kumar Singh, Abhishek Singh, Shantanu Kumar Singh, and Priyanka Singh, Taj Pharma has achieved remarkable growth, offering a broad therapeutic portfolio that includes antiviral, antidiabetic, cardiovascular, CNS, and oncology formulations. Its state-of-the-art Sarigam facility boasts advanced technology with a monthly production capacity of 120 million tablets, 40 million capsules, and 60 million oral jellies.
With a strong commitment to innovation, regulatory compliance, and sustainability, Taj Pharma maintains global standards through stringent QA/QC systems and exports to markets across Asia, Africa, the Middle East, and Latin America. Supported by its UK-based nutraceutical arm, Taj Nutra UK (Purobein brand), the company continues to deliver reliable, affordable, and high-quality healthcare solutions worldwide—solidifying its reputation as a trusted global pharmaceutical partner.
